*Some Market data delayed by 15 mins.

Rezolute, Inc. Common Stock (NV)

Symbol: RZLT (NASDAQ)
9.73 ▲ (3.46%) 0.325

Company Description:
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Key Stats
  • Today's Open: $9.43
  • Today's High: $9.725
  • Today's Low: $9.175
  • Today's Volume: 2.00M
  • Yesterday Close: $9.4
  • Yesterday High: $9.42
  • Yesterday Low: $8.97
  • Yesterday Volume: 2.44M
  • Last Min Volume: 3
  • Last Min High: $9.725
  • Last Min Low: $9.725
  • Last Min VWAP: $9.725
Company Profile
  • Name: Rezolute, Inc. Common Stock (NV)
  • Website: https://www.rezolutebio.com
  • Listed Date: 2011-12-23
  • Location: REDWOOD CITY, CA
  • Market Status: Active
  • CIK Number: 0001509261
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $853.63M
  • Round Lot: 100
  • Outstanding Shares: 90.81M
  • Asset Type: CS
RECENT FILINGS FOR RZLT
Filing Date Filing Type Format
2025-09-22 SCHEDULE 13G View
2025-09-17 10-K View
2025-09-17 8-K View
2025-09-02 8-K View
2025-08-27 4 View
2025-08-27 3 View
2025-08-20 8-K View
2025-08-08 EFFECT View
2025-08-06 SCHEDULE 13G/A View
2025-08-01 CORRESP View
2025-07-24 UPLOAD View
2025-07-18 8-K View
2025-07-17 S-3 View
2025-06-26 4 View
2025-06-24 4 View
2025-06-23 4 View
2025-06-23 4 View
2025-06-13 4 View
2025-06-13 8-K/A View
2025-06-13 8-K View
Latest News on RZLT

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.